Chemotherapy is standard care in resected gastric cancer (GC). Despite the evidence that combination chemotherapy (CT) increases overall survival (OS) as compared to single agent therapy in metastatic disease, no study proved this benefit in the adjuvant setting. We performed a systematic review and meta-analysis based on trial data on the role of combination over single agent CT as adjuvant treatment of GC.
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer : A systematic review and meta-analysis of published trials / R. Iacovelli, F. Pietrantonio, C. Maggi, F. de Braud, M. Di Bartolomeo. - In: CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. - ISSN 1879-0461. - 98(2016 Feb), pp. 24-28. [10.1016/j.critrevonc.2015.09.002]
Combination or single-agent chemotherapy as adjuvant treatment of gastric cancer : A systematic review and meta-analysis of published trials
F. PietrantonioSecondo
;C. Maggi;F. de BraudPenultimo
;
2016
Abstract
Chemotherapy is standard care in resected gastric cancer (GC). Despite the evidence that combination chemotherapy (CT) increases overall survival (OS) as compared to single agent therapy in metastatic disease, no study proved this benefit in the adjuvant setting. We performed a systematic review and meta-analysis based on trial data on the role of combination over single agent CT as adjuvant treatment of GC.| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S1040842815300433-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
960.78 kB
Formato
Adobe PDF
|
960.78 kB | Adobe PDF | [it] Default value: Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR




